Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial

Joseph P. Casazza, Evan M. Cale, Sandeep Narpala, Galina V. Yamshchikov, Emily E. Coates, Cynthia S. Hendel, Laura Novik, LaSonji A. Holman, Alicia T. Widge, Preeti Apte, Ingelise J. Gordon, Martin R. Gaudinski, Michelle Conan-Cibotti, Bob C. Lin, Martha Nason, Olga Trofymenko, Shinyi Telscher, Sarah H. Plummer, Diane Wycuff, William C. Adams, Janardan P. Pandey, Adrian B. McDermott, Mario Roederer, Avery N. Sukienik, Sijy O’Dell, Jason G. Gall, Britta Flach, Travis L. Terry, Misook Choe, Wei Shi, Xuejun Chen, Florence Kaltovich, Kevin O. Saunders, Judy Stein, Nicole A. Doria‐Rose, Richard Schwartz, Alejandro B. Balazs, David Baltimore, Gary J. Nabel, Richard A. Koup, Barney S. Graham, Julie E. Ledgerwood, John R. Mascola, the VRC 603 Study Team, Charla Andrews, Anita Arthur, Seemal F. Awan, Allison Beck, Eugeania Burch, Maria Claudia Burgos Florez, Nina M. Berkowitz, Eli Boritz, Kevin Carlton, Cora Trelles Cartagena, Christina Carter, Grace Chen, Pamela Costner, Jennifer Cunningham, Daniel C. Douek, Aba M. Eshun, Catina Evans, Renunda Hicks, Katherine V. Houser, Justine Jones, Brenda Larkin, Lam Le, Floreliz Mendoza, Stephen A. Migueles, John Misasi, Thuy A. Nguyen, Abidemi Ola, Karen Parker, Iris Pittman, La’ Shawn Requilman, Ro Shauna Rothwell, Gretchen L. Schieber, Jamie Saunders, Sandra Sitar, Colin Tran, Olga Trofymenko, Olga Vasilenko, Sana Waheed, Lingshu Wang, Xiaolin Wang, William Whalen, Pernell Williams, Richard L. C. Wu, Kathy Zephir